He is also an advisor to the FDA, and has been a medical advisor for Cytodyn for years.
Massimo Cristofanilli, the lead researcher listed in the Abstract is solid validation that Leronlimab is a real possible game changer when it comes to mTNBC. A google search will tell you all you need to know about him.